Abstract
Cancer metastasis is the main attribute to cancerrelated deaths and early detection is one of the most effective means to treat the disease. Spreading of cancer to distant sites is achieved usually through the circulatory system and the number of circulating tumor cells (CTCs) in peripheral blood is strongly associated to cancer development. Thus detecting CTCs in blood samples will be helpful in identifying susceptible subjects. Here, we propose a label-free technique to isolate these cancerous cells from blood. Using cancer cells spiked in blood samples, isolation efficiency of at least 80% were obtained with high isolation purity. The microdevice also preserved the integrity of the isolated cells to allow further studies to be done on these cells. These results showed a potential effective microdevice for CTCs studies and possible clinical application.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Chambers A F, Groom A C and MacDonald I C (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572
Lee G Y H and Lim C T (2007) Biomechanics approaches to studying human diseases. Trends Biotechnol 25:111–118
Steeg P S (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895–904
Heyder C, Gloria-Maercker E, Hatzmann W, et al. (2006) Visualization of tumor cell extravasation. Contrib Microbiol 13:200–208
Cristofanilli M, Budd G T, Ellis M J, et al. (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781–791
Reuben J M, Krishnamurthy S, Woodward W, et al. (2008) The role of circulating tumor cells in breast cancer diagnosis and prediction of therapy response. Expert Opinion on Medical Diagnostics 2:339–348
Balic M, Dandachi N, Hofmann G, et al. (2005) Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B Clin Cytom 68:25–30
Cristofanilli M, Broglio K R, Guarneri V, et al. (2007) Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer 7:471–479
Lara O, Tong X, Zborowski M, et al. (2004) Enrichment of rare cancer cells through depletion of normal cells using density and flowthrough, immunomagnetic cell separation. Exp Hematol 32:891–904
Pantel K, Brakenhoff R H and Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329–340
Shelby J P, White J, Ganesan K, et al. (2003) A microfluidic model for single-cell capillary obstruction by Plasmodium falciparuminfected erythrocytes. 100:14618–14622
Mohamed H, McCurdy L D, Szarowski D H, et al. (2004) Development of a rare cell fractionation device: application for cancer detection. IEEE Trans Nanobioscience 3:251–256
Weiss L (1990) Metastatic inefficiency. Adv Cancer Res 54:159–211
Weiss L and Dimitrov D S (1986) Mechanical aspects of the lungs as cancer cell-killing organs during hematogenous metastasis. J Theor Biol 121:307–321
Tan S J, Yobas L, Lee G Y H, et al. (2008) Microdevice for Isolating Viable Circulating Tumor Cells, International Conference on Biocomputation, Bioinformatics, and Biomedical Technologies, 2008. BIOTECHNO’ 08., Bucharest, Romania, 2008, pp. 109–113
McDonald J C, Duffy D C, Anderson J R, et al. (2000) Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis 21:27–40
Urtishak S, Alpaugh R K, Weiner L M, et al. (2008) Clinical utility of circulating tumor cells: a role for monitoring response to therapy and drug development. Biomarkers in Medicine 2:137–145
Dawood S, Broglio K, Valero V, et al. (2008) Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer
Allard W J, Matera J, Miller M C, et al. (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10:6897–6904
Nagrath S, Sequist L V, Maheswaran S, et al. (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450:1235–1239
Went P T, Lugli A, Meier S, et al. (2004) Frequent EpCam protein expression in human carcinomas. Hum Pathol 35:122–128
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 International Federation of Medical and Biological Engineering
About this paper
Cite this paper
Tan, S.J., Yobas, L., Lee, G.Y.H., Ong, C.N., Lim, C.T. (2009). Microdevice for Trapping Circulating Tumor Cells for Cancer Diagnostics. In: Lim, C.T., Goh, J.C.H. (eds) 13th International Conference on Biomedical Engineering. IFMBE Proceedings, vol 23. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-92841-6_190
Download citation
DOI: https://doi.org/10.1007/978-3-540-92841-6_190
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-92840-9
Online ISBN: 978-3-540-92841-6
eBook Packages: EngineeringEngineering (R0)